New drug SPG601 aims to boost brain function in fragile x patients
NCT ID NCT07439510
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new drug called SPG601 in adult men with Fragile X syndrome. The goal is to see if it can improve thinking and brain function. About 248 participants will receive either the drug or a placebo. The study is not yet recruiting.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FRAGILE X SYNDROME (FXS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New drug trial aims to ease fragile x symptoms in men
- Light-Based brain scan could revolutionize diagnosis of rare genetic disorders
- Intensive brain training shows promise for kids with developmental delays
- Scientists to unravel trust in intellectual disability
- Scientists scan brains of people with autism and fragile x to spot key differences